Quidel | QDEL - Ordinary Share Capital


Quidel reported $67.9M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Agilent USD 282.22M 478K Mar/2026
Avanos Medical USD 46.67M 216.61K Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bruker USD 152.22M 282K Mar/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Danaher USD 707.7M 800K Mar/2026
Haemonetics USD 46.83M 82K Dec/2025
Illumina USD 151.91M 893K Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Merit Medical Systems USD 59.65M 231K Mar/2026
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Neogen USD 217.67M 147K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quidel USD 67.9M 0 Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Waters USD 98.17M 89K Mar/2026